This minireview discusses vasomotion, which is the oscillation in tone of blood vessels leading to flowmotion. We will briefly discuss the prevalence of vasomotion and its potential physiological and pathophysiological relevance. We will also discuss the models that have been suggested to explain how a coordinated oscillatory activity of the smooth muscle tone can occur and emphasize the role of the endothelium, the handling of intracellular Ca(2+) and the role of smooth muscle cell ion conductances. It is concluded that vasomotion is likely to enhance tissue dialysis, although this concept still requires more experimental verification, and that an understanding at the molecular level for the pathways leading to vasomotion is beginning to emerge.

Abstract-Although the biophysical fingerprints (ion selectivity, voltage-dependence, kinetics, etc) of Ca 2ϩ -activated Cl Ϫ currents are well established, their molecular identity is still controversial. Several molecular candidates have been suggested; however, none of them has been fully accepted. We have recently characterized a cGMP-dependent Ca 2ϩ -activated Cl Ϫ current with unique characteristics in smooth muscle cells. This novel current has been shown to coexist with a "classic" (cGMP-independent) Ca 2ϩ -activated Cl Ϫ current and to have characteristics distinct from those previously known for Ca 2ϩ -activated Cl Ϫ currents. Here, we suggest that a bestrophin, a product of the Best gene family, is responsible for the cGMP-dependent Ca 2ϩ -activated Cl Ϫ current based on similarities between the membrane currents produced by heterologous expressions of bestrophins and the cGMP-dependent Ca 2ϩ -activated Cl Ϫ current. This is supported by similarities in the distribution pattern of the cGMP-dependent Ca 2ϩ -activated Cl Ϫ current and bestrophin-3 (the product of Best-3 gene) expression in different smooth muscle. Furthermore, downregulation of Best-3 gene expression with small interfering RNA both in cultured cells and in vascular smooth muscle cells in vivo was associated with a significant reduction of the cGMP-dependent Ca 2ϩ -activated Cl Ϫ current, whereas the magnitude of the classic Ca 2ϩ -activated Cl Ϫ current was not affected. Ϫ channel, which results in depolarization in vascular smooth muscle. Furthermore, the current is of similar magnitude as "classic" Ca 2ϩ -activated Cl Ϫ currents in most vascular beds and even larger in some vascular smooth muscles. 3 It is, therefore, highly desirable to know the molecular structure of the channel responsible for this current because it is likely to play an important role in smooth muscle function.Although their biophysical fingerprints (ion selectivity, voltage-dependence, kinetics, etc) are well established, 4 -6 the molecular identity of Ca 2ϩ -sensitive Cl Ϫ channels is still controversial. 7 Recently, the gene responsible for vitelliform macular dystrophy 8 and its homologs that code for bestrophin proteins have been suggested as candidates. 9,10 Four bestrophin family members in the mammalian genome and many homologues in genomes of invertebrates and even prokaryotes have been identified. 11-13 Two different nomenclatures for mammalian bestrophins were previously devel- The majority of suggestions that bestrophins function as Cl Ϫ channels are based on the findings that expression of the gene in different cell types leads to the appearance of a Cl Ϫ conductance 9,10 and that mutations or chemical modifications of the predicted channel pore change this conductance. [15][16][17][18] Although downregulation by small interfering (si)RNA in recent studies demonstrated a direct association between the endogenous Cl Ϫ current in epithelial cell culture and Best-1 expression, 19 -21 the exact role of the bestrophins in native tissues remains questionable...

Abstract:The vascular supply to the human bladder is derived mainly from the superior and inferior vesical arteries, the latter being directly connected to the internal iliac artery. Aging is associated with an impairment of blood vessel function and changes may occur in the vasculature at the molecular, cellular and functional level. Pelvic arterial insufficiency may play an important role in the development of bladder dysfunctions such as detrusor overactivity (DO) and the overactive bladder syndrome. Chronic ischemia-related bladder dysfunction may progress to bladder underactivity and it would be desirable to treat not only lower urinary tract symptoms (LUTS) induced by chronic ischemia, but also the progression of the morphological bladder changes. Studies in experimental models in rabbits and rats have shown that pelvic arterial insufficiency may result in significant bladder ischemia with reduced bladder wall oxygen tension. In turn, this will lead to oxidative stress associated with upregulation of oxidative stress-sensitive genes, increased muscarinic receptor activity, ultrastructural damage, and neurodegeneration. The phosphodiesterase type 5 (PDE5) inhibitor tadalafil, the α 1 -adrenoceptor (AR) blocker silodosin, the β 3 -AR agonist mirabegron, and the free radical scavenger melatonin, exerted a protecting effect on urodynamic parameters, and on functional and morphological changes of the bladder demonstrable in vitro. Since the agents tested are used clinically for relieving LUTS, the results from the animal models seem to have translational value, and may be of relevance for designing clinical studies to demonstrate if the drugs may prevent progression of ischemia-related functional and morphological bladder changes.

We investigate sensing and signaling mechanisms for H þ , HCO